Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Sorrento Therapeutics, Inc. | exhibit321.htm |
| EX-31.2 - EXHIBIT 31.2 - Sorrento Therapeutics, Inc. | exhibit312.htm |
| EX-31.1 - EXHIBIT 31.1 - Sorrento Therapeutics, Inc. | exhibit311.htm |
| 10-Q - 10-Q - Sorrento Therapeutics, Inc. | srne6301810-q.htm |
Exhibit 12.1
Sorrento Therapeutics, Inc.
Ratio of Earnings to Fixed Charges
(Dollars in thousands)
Six Months Ended | Fiscal Year Ended December, 31 | |||||||
(in $ thousands) | June 30, 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||
Pretax Income (Loss) from Continuing Operations | (107,653) | 15,315 | (65,268) | (9,719) | (36,359) | (21,911) | ||
Fixed Charges (per below) | 46,136 | 5,201 | 1,712 | 1,651 | 1,628 | 254 | ||
Interests Capitalized | - | - | - | - | - | - | ||
Earnings | (61,517) | 20,516 | (63,556) | (8,068) | (34,731) | (21,657) | ||
Interests and Other Financial Charges | 46,032 | 4,980 | 1,615 | 1,651 | 1,628 | 254 | ||
Interests Portion of Rental Expense | 104 | 221 | 97 | - | - | - | ||
Fixed Charges | 46,136 | 5,201 | 1,712 | 1,651 | 1,628 | 254 | ||
Ratio of Earnings to Fixed Charges | (1.3) | 3.9 | (37.1) | (4.9) | (21.3) | (85.3) | ||